These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 11832095

  • 1. [Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal neoplasm].
    Wan Y, Wei Q, Pan Y, Liu Y.
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):510-3. PubMed ID: 11832095
    [Abstract] [Full Text] [Related]

  • 2. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX, Li L, Li DR, Zhang W, Cheng XQ, Zhang JQ, Tang BJ.
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [Abstract] [Full Text] [Related]

  • 3. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
    Pesta M, Holubec L, Topolcan O, Cerna M, Rupert K, Holubec LS, Treska V, Kormunda S, Elgrova L, Finek J, Cerny R.
    Anticancer Res; 2005 Oct; 25(5):3387-91. PubMed ID: 16101153
    [Abstract] [Full Text] [Related]

  • 4. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K, Ikebuchi M, Kanaoka Y, Ohgi S, Ueta E, Nanba E, Ito H.
    Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
    [Abstract] [Full Text] [Related]

  • 5. Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.
    Gentner B, Wein A, Croner RS, Zeittraeger I, Wirtz RM, Roedel F, Dimmler A, Dorlaque L, Hohenberger W, Hahn EG, Brueckl WM.
    Anticancer Res; 2009 Jan; 29(1):67-74. PubMed ID: 19331134
    [Abstract] [Full Text] [Related]

  • 6. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ, Chen XM, Cui SW, Cai GY, Shi SZ, Xie YS, Lu Y, Peng LX.
    Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):937-42. PubMed ID: 15329283
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
    Pesta M, Topolcan O, Holubec L, Rupert K, Cerna M, Holubec LS, Treska V, Finek J, Cerny R.
    Anticancer Res; 2007 Jun 02; 27(4A):1863-7. PubMed ID: 17649785
    [Abstract] [Full Text] [Related]

  • 8. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
    Ozen O, Krebs B, Hemmerlein B, Pekrun A, Kretzschmar H, Herms J.
    Clin Cancer Res; 2004 Jul 15; 10(14):4746-53. PubMed ID: 15269148
    [Abstract] [Full Text] [Related]

  • 9. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T, Kunisaki C, Yoshihara K, Yamada R, Yamamoto N, Sato T, Makino H, Yamagishi S, Nagano Y, Fujii S, Shiozawa M, Akaike M, Wada N, Rino Y, Masuda M, Tanaka K, Imada T.
    Oncol Rep; 2008 May 15; 19(5):1285-91. PubMed ID: 18425389
    [Abstract] [Full Text] [Related]

  • 10. mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissue.
    Lichtinghagen R, Musholt PB, Stephan C, Lein M, Kristiansen G, Hauptmann S, Rudolph B, Schnorr D, Loening SA, Jung K.
    Anticancer Res; 2003 May 15; 23(3B):2617-24. PubMed ID: 12894549
    [Abstract] [Full Text] [Related]

  • 11. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma.
    Asano T, Tada M, Cheng S, Takemoto N, Kuramae T, Abe M, Takahashi O, Miyamoto M, Hamada J, Moriuchi T, Kondo S.
    J Surg Res; 2008 May 01; 146(1):32-42. PubMed ID: 17543340
    [Abstract] [Full Text] [Related]

  • 12. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers.
    Curran S, Dundas SR, Buxton J, Leeman MF, Ramsay R, Murray GI.
    Clin Cancer Res; 2004 Dec 15; 10(24):8229-34. PubMed ID: 15623598
    [Abstract] [Full Text] [Related]

  • 13. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
    Baker EA, Bergin FG, Leaper DJ.
    Br J Surg; 2000 Sep 15; 87(9):1215-21. PubMed ID: 10971431
    [Abstract] [Full Text] [Related]

  • 14. Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines.
    Daja MM, Niu X, Zhao Z, Brown JM, Russell PJ.
    Prostate Cancer Prostatic Dis; 2003 Sep 15; 6(1):15-26. PubMed ID: 12664060
    [Abstract] [Full Text] [Related]

  • 15. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.
    O-Charoenrat P, Rhys-Evans PH, Eccles SA.
    Arch Otolaryngol Head Neck Surg; 2001 Jul 15; 127(7):813-20. PubMed ID: 11448356
    [Abstract] [Full Text] [Related]

  • 16. [Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia].
    Zhang H, Lin QD, Qiao C.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug 15; 41(8):509-13. PubMed ID: 17083831
    [Abstract] [Full Text] [Related]

  • 17. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F, Sumi T, Okamoto E, Nobeyama H, Hattori K, Yoshida H, Matsumoto Y, Yasui T, Honda K, Ishiko O.
    Int J Mol Med; 2005 Oct 15; 16(4):541-6. PubMed ID: 16142384
    [Abstract] [Full Text] [Related]

  • 18. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2.
    Kayano K, Shimada T, Shinomiya T, Nakai S, Hisa Y, Aoki T, Seiki M, Okada Y.
    J Pathol; 2004 Apr 15; 202(4):403-11. PubMed ID: 15095267
    [Abstract] [Full Text] [Related]

  • 19. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
    He DS, Chen MZ, Wang HJ, Ke CL, Yan C, Zheng H, Hong YS.
    Ai Zheng; 2002 Oct 15; 21(10):1124-8. PubMed ID: 12508658
    [Abstract] [Full Text] [Related]

  • 20. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
    Voland P, Besig S, Rad R, Braun T, Baur DM, Perren A, Langer R, Höfler H, Prinz C.
    Neuroendocrinology; 2009 Oct 15; 89(1):66-78. PubMed ID: 18708724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.